Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A review of rifaximin and bacterial overgrowth in poorly responsive celiac disease.

A review of rifaximin and bacterial overgrowth in poorly responsive celiac disease. Therap Adv Gastroenterol. 2012 Jan; 5(1):31-6.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.